0% found this document useful (0 votes)
116 views41 pages

Overview of Blood Components and Uses

Blood components are products derived from whole blood through centrifugation or apheresis that allows for individual components to be transfused to multiple patients. Common blood components include red blood cells, platelets, fresh frozen plasma, cryoprecipitate, and granulocyte concentrates. Proper storage and processing of blood components helps maintain viability and function while minimizing contamination.

Uploaded by

nighat khan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
116 views41 pages

Overview of Blood Components and Uses

Blood components are products derived from whole blood through centrifugation or apheresis that allows for individual components to be transfused to multiple patients. Common blood components include red blood cells, platelets, fresh frozen plasma, cryoprecipitate, and granulocyte concentrates. Proper storage and processing of blood components helps maintain viability and function while minimizing contamination.

Uploaded by

nighat khan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

Blood Components

Compiled by Dr Chizoba Nwankwo


BLOOD COMPONENTS
• Blood components are those products derived
from whole blood collected from normal
donors by
[Link] or

[Link] using the techniques of


different centrifugation.
• It enhances the utilization of individual
donations for several patients and decreases
the need for whole blood.
BLOOD COMPONENTS
• Whole blood comprises of cellular elements
and plasma
• Some plasma derivatives are prepared from
large pools of human plasma under
pharmaceutical manufacturing conditions
eg albumin, coagulation factors ,
immunoglobulins.
Blood components

Picture from internet


Separation of blood components
• Is carried out in double or triple bags with
closed integral tubing
• Separation is done in cold centrifuge.
• Due to different specific gravity of cellular
components, they can be separated by
centrifuging.
Separation of blood components

Pictures from internet


Apheresis
• Apheresis = separation, derived from greek
word “take away”
• Process in which whole blood is withdrawn
, separated into component parts; the
desired component is retained ,while the
remainder is returned to the donor/patient
Apheresis applications

1. Plasmapheresis
2. Cytapheresis
a) Plateletpheresis Single donor platelet collection

b) Leukapheresis
Peripheral blood stem cell collection
Donor lymphocyte collection
Granulocyte collection

c) Erythrocytapheresis
Apheresis machine- Optia
Additional processing
• Irradiation of cellular components
• Washing of cellular components
• Platelets in platelet additive solution
• Pathogen inactivation/reduction for FFP
and cryoprecipitate
• Small volume components for neonatal use
• Concentration of red cells or platelets for
intrauterine transfusion
leucodepletion
• Blood products should be routinely filtered to
remove majority of wbc,
• A blood component is defined as leucocyte
depleted if there are <5 x106 wbc present..
• Leucodepletion reduces the incidence of
febrile transfusion reaction and HLA
alloimmunization, prevents transmission of
Variant Creutzfeldt Jakob Disease
Irradiation of blood components
• Transfusion containing viable lymphocytes can result in
GVHD.
• 25gy of external radiation to blood components can
render lymphocytes incapable of post transfusion graft
versus host disease.
• Indication for blood irradiation,
– Cytopenia from whole body irradiation exposure.
– Haemopoietic transplant
– Immunocompromised recipient of organ transplant.
– Intrauterine transfusion
Goals Of Blood Collection
• Maintain viability and function
• Prevent physical changes
• Minimize bacterial contamination
Storage Lesion
• Biochemical changes
– pH decreases
– 2,3 DPG decreases
– ATP decreases, glucose decreases
– Potassium increases, Sodium decreases,loss of
Ca
• Clotting factors V,VIII decrease
• Few functional platelets present
• Viable (living) RBCs decrease
Anticoagulants Preservative
Solutions
• Anticoagulants prevent blood clotting
• Preservatives provide nutrients for cells
• Heparin
– Rarely if ever used anymore
– Anticoagulant ONLY
– Transfuse within 48 hours, preferably 8
Action of ingredients of anticoagulant
solution
• Glucose - supports ATP generation by
glycolytic pathways
• Adenine -synthesizes ATP, increases level
of ATP, extends the shelf-life of red cells.
• Citrate - prevents coagulation by chelating
calcium.
• Sodium di-phosphate –prevents fall in pH
Anticoagulants
• Acidified ditrate dextrose (ACD)
• Citrate-phosphate-dextrose (CPD)
• Citrate-phosphate-dextrose with adenine
(CPDA-1)
• Heparin
Anticoagulants
CPD or CP2-D CPD-A1
Storage time 21 days 35 days
Temperature 2-6 C 2-6 C
Slows glycolytic activity
Adenine None Substrate for ATP synthesis
Volume 450 +/- 10%
Dextrose Supports ATP generation by glycolytic
pathway
Citrate Prevents coagulation by binding calcium
Various blood components
• Red cells
• Granulocyte concentrate
• Platelet concentrate
• Plasma derivatives
– Conc of specific plasma proteins that are prepared from
pools of plasma.
– Obtained through a process known as fractionation, are
heat treated and /or solvent detergent treated to kill
certain viruses e.g. HIV, Hep B, C
– eg FFP,Albumin, cryoprecipitate, freeze dried factor VIII,
IX- Prothrombin complex conc., Protein C,
[Link] D Ig (Rhogam)
RBC Transfusions
Preparations
• Type
– Blood group of RBC’s for ABO and Rh are determined
for both donor and recipient
• Screen
– Screen for atypical antibodies
– Approx 1-2% of patients have antibodies
• Crossmatch
– Donor cells and recipient serum are mixed and
evaluated for agglutination
Whole Blood
• Storage
– Stored 4° for up to 35 days
• Indications
– Massive Blood Loss/Trauma/Exchange Transfusion
• Considerations
– Donor and recipient must be ABO identical
Fresh Whole Blood
• Clinicians may request for fresh whole blood
( blood less than 24 hours)
• It is requested when there is anemia and
bleeding disorder by platelet, coagulation factor
deficiency since platelets and labile coagulation
factors become functionally ineffective after 48
hours of storage
• Can be used for neonatal blood exchange
• if available, packed red cells, plasma
components,or platelet concentrates are more
effective and preferred forms of therapy for such
patients
Fresh Whole Blood
• Useful in managing conditions associated
with loss of whole blood like road traffic
accident , in obstetrics ( uterine rupture, post
partum hemorrhage etc) and bone marrow
failure where all the cell lineage are
depressed.
Red cells
They are available in 4 different types
• Packed red cells
• Red cell concentrate
• Leucocyte depleted red cells (LDRC)
• Washed red cells
Red cells
• Packed red cells-
– 2/3 of the donor plasma is removed.
– PCV is about 70%
• Red cell concentrate
– Nearly all visible donor plasma has been
removed,useful in patient with allergic reaction
– PCV- 90%
– It is very viscous and need wide bore cannula
Red Cells
• Leucocyte depleted red cells (LDRC)
– More than 99% of WBC has been removed by
filtration or centrifugation
– Useful in patient with history of febrile
transfusion reaction
• Washed red cells
– Has no trace of donor plasma, the cells are
washed with saline and additive solution added
– Useful in IgA negative individuals
RBC Concentrate
• Storage is 4° for up to 42 days depending
on anticoagulant used, can be frozen
• Indications are anemia, hypoxia, etc.
• Washed red cells have plasma protein,
electrolytes, antibodies removed and has 24
hrs expiration.
• Frozen, thawed, deglycerolized red cells are
not routinely done, useful in autologous
units before surgery and rare blood, last
10yrs when frozen
Platelets
• Storage is at room temp 20-220c and prone to
bacteria contamination, has shelf life of 5 days in
packs of plastic with agitation to prevent
aggregation

• Indications
– Thrombocytopenia, Plt <15,000
– Bleeding and Plt <50,000
– Invasive procedure and Plt <50,000
• Considerations
– Contain Leukocytes and cytokines
Platelets concentrates
• Patients requiring frequent platelet transfusions
are advised to be vaccinated against Hepatitis
B.
• Patients who receive repeated platelet
transfusions are well advised to use a single-
donor product, thereby decreasing the risk of
alloimmunization to HLA and glycoprotein
antigens.
• Alloimmunization can lead to refractoriness to
transfusions.
Fresh plasma
• This plasma that is prepared and used
within 6 hours of collection from a normal
blood donor
• It is used to treat bleeding conditions
associated with deficiency of clotting
factors
• See other indication of use like in Fresh
frozen plasma
Fresh Frozen Plasma FFP
• Contents—Coagulation Factors (1 unit/ml)
• frozen to -300 c and viable for one year. When
needed thawed at 37oc and transfused immediately
• Indications
– Coagulation Factor deficiency, fibrinogen
replacement, DIC, liver disease, exchange
transfusion, massive transfusion
– Usual dose is 20 ml/kg to raise coagulation
factors approx 20%
Cryoprecipitate
• Description
– Precipitate formed/collected when FFP is thawed at 4°.
Contains von willebrand factor, Factor VIII,
plasminogen activator and fibrinogen
• Storage
– After collection, refrozen and stored up to 1 year at -
18°
• Indication
– Fibrinogen deficiency or dysfibrinogenemia
– vonWillebrands Disease
– Factor VIII or XIII deficiency
– DIC (not used alone)
• Considerations
– ABO compatible preferred (but not limiting)
Cryosupernatant.

• Indication is plasma exchange in TTP, because


it supplies more of the metalloproteinase and
lacks HMW multipliers.
• Stored at -30 o c or below for 24 months.
• Do not use for condition that require vWF or
factor VIII replacement
Granulocyte Concentrate
• Prepared at the time for immediate transfusion (no
storage available)
• Indications – severe neutropenia assoc with
infection that has failed antibiotic therapy, and
recovery of BM is expected
• Donor is given G-CSF and steroids or Hetastarch
• Complications
– Severe allergic reactions, may transmit CMV
– Can irradiate granulocytes for GVHD prevention
Human albumin solution (4.5%)
• Useful plasma volume expander when a sustained
osmotic effect is required prior to administration of
blood.
• For fluid replacement in patient undergoing
plasmapheresis and sometimes in selected patient
with hypoalbuminaemia.
Human albumin solution (20%) salt poor
• For severe hypoalbuminaemia especially in liver
disease and nephrotic syndrome. Excessive burn
Factor VIII freeze-dried concentrate.
• For treating haemophilia A or [Link] use is declining
with recombinant factor available.

Freeze –dried factor IX- prothrombin


complex.
• A number of preparations are available that contain
factor II, VIII, IX and X.
• Used for treating Factor IX def, liver disease or
overdose with oral anticoagulant or patient with factor
VIII inhibitiors.
• There is a risk of thrombosis.
Prothrombin Complex Concentrate (PCC)
• contains factors II, IX, and X, and
sometimes also F VII.
• PCC contains trace amounts of activated
coagulation factor and can result in
thrombosis
• Used in
– Haemophilia A with inhibitor antibodies against
F VIII and who are nonresponsive to F VIII
concentrate
– Inherited factor Ix, X and II deficiency
PCC
• PCCs have replaced frozen plasma as the
product of choice for emergency reversal of
warfarin effect or vitamin K deficiency
• Off label use include the reversal of anti-Xa
inhibitors (Rivaroxaban and Apixiban
• Products available are Octaplex® and
Beriplex®
Specific Immunoglobulin
• Obtained from donors with high titre of
antibodies, anti-RhD, anti hepatitis B, anti
herpes Zoster or anti-rubella.
Selection of ABO Donor Units
• Questions
• What are the blood group selection for
transfusion of plasma and platelet eg what
blood group can donate plasma to recipient
O
• AB is the only universal plasma to all
recipient

You might also like